Thursday, February 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Commodities

Almonty Shares Slide Despite Strategic Expansion Moves

Robert Sasse by Robert Sasse
November 5, 2025
in Commodities, Earnings, Value & Growth
0
Almonty Stock
0
SHARES
36
VIEWS
Share on FacebookShare on Twitter

Almonty Industries witnessed a significant 9.4% decline in its share price, closing at CAD $9.03, as disappointing quarterly operational results overshadowed positive corporate developments. The Canadian tungsten producer reported a 28% revenue increase to CAD $8.7 million but failed to meet market expectations.

The company posted an operating loss of CAD $2.2 million, substantially below analyst projections. In a surprising twist, Almonty recorded a net profit of CAD $33.2 million, primarily driven by financial instrument revaluations that offset operational challenges.

Strategic Acquisition Positions Company for US Defense Contracts

Beyond the quarterly figures, Almonty executed a strategic masterstroke with its recent acquisition of the Gentung-Browns Lake tungsten project in Montana for $10 million. This purchase could establish the company as a primary tungsten supplier to the United States defense sector.

CEO Lewis Black confirmed that production at the Montana site could commence as early as the second half of 2026. This timeline aligns perfectly with the US Department of Defense’s planned 2027 prohibition on tungsten sourcing from China, Russia, and North Korea.

Key advantages of the Montana project include:
* An existing 15-year offtake agreement with a US defense contractor
* Contractual coverage for over 90% of initial production capacity
* Utilization of processed equipment from Spanish operations
* Established water rights and infrastructure accelerating development

Should investors sell immediately? Or is it worth buying Almonty?

Global Expansion Strategy Advances Simultaneously

While pursuing its US offensive, Almonty continues to advance projects across Europe and Asia. At its flagship Panasqueira operation in Portugal, the company launched an extensive drilling program targeting Level 4 – a new production tier expected to extend mine life and boost annual output.

In South Korea, drilling activities at the Sangdong project – one of the largest tungsten deposits outside China – are focusing on the molybdenum component. This strategic move addresses global shortages of this critical metal directly.

Market analysts remain cautiously optimistic about Almonty’s prospects. DA Davidson maintains its “Buy” recommendation with a US $11.00 price target, indicating confidence in the company’s long-term strategy despite current operational headwinds.

Critical Months Ahead for Execution

The coming months will prove decisive for Almonty’s trajectory. Regulatory approvals in Montana and drilling results from Portugal will demonstrate whether the company can translate strategic positioning into operational success. If successfully executed, Almonty stands to benefit disproportionately from ongoing trade conflicts and supply chain restructuring.

Nevertheless, significant challenges persist. Concurrent development of multiple projects, substantial capital requirements, and operational inefficiencies continue to pressure the company’s financial performance. Investors now face the crucial decision of whether the recent price decline represents a buying opportunity or signals further downward momentum.

Ad

Almonty Stock: Buy or Sell?! New Almonty Analysis from February 5 delivers the answer:

The latest Almonty figures speak for themselves: Urgent action needed for Almonty investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 5.

Almonty: Buy or sell? Read more here...

Tags: Almonty
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Arafura Stock
Analysis

Arafura’s Rare Earths Project Faces Revised Timeline for Final Investment Decision

February 5, 2026
Intuitive Surgical Stock
Analysis

Intuitive Surgical Shares Face Pressure Amid Growth Concerns

February 5, 2026
Beyond Meat Stock
Analysis

Legal Challenge Adds Pressure to Beyond Meat’s Strategic Pivot

February 5, 2026
Next Post
La-Z-Boy Stock

La-Z-Boy Shares Plummet to New Low Ahead of Critical Earnings Report

Nel ASA Stock

Norwegian Hydrogen Leader Faces Mounting Challenges

Compass Therapeutics Stock

Compass Therapeutics Shares Surge on Promising Cancer Drug Data

Recommended

Deutsche Bank Stock

Deutsche Bank Charts Independent Course Under CEO Sewing’s Strategy

5 months ago

Financial Moves of First Watch Restaurant Group Incs Chief Brand Officer

2 years ago
Verisign Stock

Insider Selling and Analyst Optimism Create Verisign Conundrum

6 months ago
Businesses finance

Chardan Capital Reaffirms Buy Rating for Dyne Therapeutics with Price Target Increase

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Coastal Financial: A Niche-Focused Strategy in Digital Banking

Dynavax Nears Final Chapter with Sanofi Acquisition

Alibaba’s AI Ambition: A Costly Gamble for User Growth

Newmont Mining Shares: Analyst Optimism Meets Operational Setback

Applied Digital’s Strategic Pivot: AI Infrastructure Ambitions Fueled by Major Contracts and Financing

iRobot Exits Public Markets Following Bankruptcy and Acquisition

Trending

Arafura Stock
Analysis

Arafura’s Rare Earths Project Faces Revised Timeline for Final Investment Decision

by Andreas Sommer
February 5, 2026
0

The timeline for a crucial investment decision regarding a major Australian rare earths development has been extended....

Intuitive Surgical Stock

Intuitive Surgical Shares Face Pressure Amid Growth Concerns

February 5, 2026
Beyond Meat Stock

Legal Challenge Adds Pressure to Beyond Meat’s Strategic Pivot

February 5, 2026
Coastal Stock

Coastal Financial: A Niche-Focused Strategy in Digital Banking

February 5, 2026
Dynavax Stock

Dynavax Nears Final Chapter with Sanofi Acquisition

February 5, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Arafura’s Rare Earths Project Faces Revised Timeline for Final Investment Decision
  • Intuitive Surgical Shares Face Pressure Amid Growth Concerns
  • Legal Challenge Adds Pressure to Beyond Meat’s Strategic Pivot

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com